Branislav Vohnout - Epidemiology

Author Information

Dr. Branislav Vohnout is affiliated with multiple prestigious institutions including the Diabetes and Lipid Outpatient Clinic, Diabeda s.r.o., in Bratislava, Slovakia. He is also associated with the Coordination Center for Familial Hyperlipidemias at the Institute of Nutrition, Department of Diabetes, Slovak Medical University, and the Department of Epidemiology at the School of Medicine, Comenius University, both located in Bratislava, Slovakia.

Research Contributions

Dr. Branislav Vohnout has made significant contributions to the field of epidemiology, particularly in the study of lipid disorders and familial hypercholesterolemia. His research spans various aspects of cardiometabolic risk factors, dietary influences, and the genetic and epigenetic underpinnings of diseases. Notably, his work on the diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms and the global perspective of familial hypercholesterolemia has been highly influential. Dr. Vohnout has also explored the impact of genetic methylation on blood cell parameters and the effectiveness of international cooperation in familial hypercholesterolemia screening and treatment.

Aliases

Dr. Branislav Vohnout is also known by the aliases B Vohnout and B. Vohnout.

Publication and Citation Metrics

Metric	Value
Citation Count	1346
h-index	18
Paper Count	62

Publications:

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

DOI: 10.1002/jcsm.12960

Year: 2022

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

DOI: 10.1016/S0140-6736(21)01122-3

Year: 2021

The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP).

DOI: 10.1016/j.clnu.2020.05.017

Year: 2020

PCSK9 inhibitors and diabetes mellitus.

DOI: 10.36290/vnl.2018.170

Year: 2019

ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort

DOI: 10.1186/s13148-019-0665-6

Year: 2019

Variation of PEAR1 DNA methylation influences platelet and leukocyte function

DOI: 10.1186/s13148-019-0744-8

Year: 2019

The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project

DOI: 10.1007/s11883-019-0797-3

Year: 2019

Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.

DOI: 10.1016/j.atherosclerosis.2018.08.008

Year: 2018

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.

DOI:

Year: 2018

Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.

DOI: 10.1016/j.atherosclerosis.2018.06.857

Year: 2018

What are the Treatment Options for Plasmodium Ovale?

What is Indoor Residual Spraying (IRS)?

What Are the Health Impacts of Inhalation Exposure?

Why is One-to-One Matching Important?

Why Are Gene-Environment Interactions Important in Epidemiology?

What is an Epidemiology Resume/CV?

Why is Multivariate Regression Important in Epidemiology?

Why are Drug-Drug Interactions Important in Epidemiology?

What Are Hospital-Acquired Infections (HAIs)?

What is the Future of Workplace Safety in Epidemiology?

Partnered Content Networks

Relevant Topics